Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis. [electronic resource]
Producer: 20100823Description: 238-45 p. digitalISSN:- 0392-856X
- Activities of Daily Living
- Adult
- Antirheumatic Agents -- administration & dosage
- Etanercept
- Female
- Humans
- Immunoglobulin G -- administration & dosage
- Injections, Subcutaneous
- Male
- Middle Aged
- Motor Activity
- Patient Satisfaction
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Spondylitis, Ankylosing -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.